Relmada Therapeutics, Inc.(RLMD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RLMD Relmada Therapeutics, Inc.

交易中 08-20 13:59:52 EDT

4.58

-0.25

-5.18%

最高4.79	最低4.55	成交量56.81万
今开4.74	昨收4.83	日振幅4.97%
总市值4.90亿	流通市值3.58亿	总股本1.07亿
成交额263.88万	换手率0.73%	流通股本7,816万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RLMD","market":"US","secType":"STK","nameCN":"Relmada Therapeutics, Inc.","latestPrice":4.58,"timestamp":1787248789034,"preClose":4.83,"halted":0,"volume":568139,"delay":0,"changeRate":-0.05175983436853002,"floatShares":78160600,"shares":107000000,"eps":-0.93,"marketStatus":"交易中","change":-0.25,"latestTime":"08-20 13:59:52 EDT","open":4.74,"high":4.79,"low":4.55,"amount":2638750.560589,"amplitude":0.049689,"askPrice":4.58,"askSize":270,"bidPrice":4.57,"bidSize":390,"shortable":3,"etf":0,"ttmEps":-0.93,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787256000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":4.83,"preHourTrading":{"tag":"盘前","latestPrice":4.68,"preClose":4.83,"latestTime":"08:19 EDT","volume":84,"amount":392.660016,"timestamp":1787228348585,"change":-0.15,"changeRate":-0.031056,"amplitude":0.00207},"postHourTrading":{"tag":"盘后","latestPrice":4.83,"preClose":4.83,"latestTime":"19:30 EDT","volume":5883,"amount":28403.58,"timestamp":1787182204615,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.91604,"impliedVol":1.2874,"impliedVolPercentile":0.5339},"requestUrl":"/m/hq/s/RLMD","defaultTab":"news","newsList":[{"id":"1173035795","title":"Relmada Therapeutics股价盘前飙升27%至5.66美元 膀胱癌药物中期数据亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1173035795","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173035795?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:44","pubTimestamp":1773056691,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics公司股价在盘前交易中大幅上涨27%，报收于5.66美元。这一显著涨幅源于其针对膀胱癌的试验性药物在中期研究阶段公布了积极数据，展现出良好的治疗潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110091863","title":"Relmada Therapeutics宣布超额认购1.6亿美元私募股权融资","url":"https://stock-news.laohu8.com/highlight/detail?id=1110091863","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110091863?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:07","pubTimestamp":1773054442,"startTime":"0","endTime":"0","summary":"佛罗里达州科勒尔盖布尔斯，2026年3月9日——临床阶段生物技术公司Relmada Therapeutics, Inc.今日宣布，已签订证券购买协议，通过非公开市场进行股权投资融资，预计将为公司带来约1.6亿美元的总收益。根据协议条款，Relmada将出售合计2947.4569万股普通股，每股作价4.75美元；同时发行421.0527万份预融资权证，每份权证定价4.749美元。Relmada作为专注于肿瘤与中枢神经系统疾病创新疗法的研发企业，其核心候选药物NDV-01和sepranolone已进入中期临床试验阶段，有望填补当前治疗领域的空白。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","RLMD","BK4539","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120259669","title":"Relmada Therapeutics公司：针对BCG无应答患者的3期二线研究初步3个月结果预计于2026年底公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1120259669","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120259669?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:05","pubTimestamp":1773054330,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics公司近日披露，其针对BCG无应答患者群体开展的3期二线研究，初步的3个月疗效数据预计将在2026年年底获得。这项研究是公司核心管线推进过程中的一个关键节点，其结果备受业界关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167411256","title":"Relmada Therapeutics公司新药NDV-01在高危NMIBC中展现76%的12个月完全缓解率","url":"https://stock-news.laohu8.com/highlight/detail?id=1167411256","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167411256?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:05","pubTimestamp":1773054329,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics公司近日公布了其研究性药物NDV-01针对高危非肌层浸润性膀胱癌的积极数据。临床结果显示，该疗法在12个月的治疗周期内，达到了76%的完全缓解率，这一数据显著超越了现有标准疗法的预期效果，为患者带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120820929","title":"Relmada Therapeutics公布Ndv-01治疗非肌层浸润性膀胱癌的12个月二期中期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1120820929","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120820929?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:03","pubTimestamp":1773054182,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics, Inc. (RLMD) 已公布其候选药物Ndv-01针对非肌层浸润性膀胱癌（NMIBC）的二期临床试验为期12个月的中期分析结果。此次数据更新提供了关于该疗法在长期疗效和安全性方面的初步洞察。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511522076","title":"Relmada Therapeutics, Inc.盘中异动 股价大涨5.15%报0.321美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511522076","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511522076?lang=zh_cn&edition=full","pubTime":"2025-02-14 00:15","pubTimestamp":1739463325,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日00时15分，Relmada Therapeutics, Inc.股票出现异动，股价快速拉升5.15%。截至发稿，该股报0.321美元/股，成交量23.9588万股，换手率0.79%，振幅8.76%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.03%。其相关个股中，Edesa Biotech, Inc.、Dominari Holdings Inc.、Pliant Therapeutics, Inc.涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为2707.91%、1167.95%、162.97%，振幅较大的相关个股有Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为95.15%、92.30%、42.61%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214001525988440c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214001525988440c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RLMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509253236","title":"Relmada Therapeutics, Inc.盘中异动 下午盘急速上涨5.79%报0.360美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509253236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509253236?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:00","pubTimestamp":1738785610,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时00分，Relmada Therapeutics, Inc.股票出现波动，股价快速拉升5.79%。截至发稿，该股报0.360美元/股，成交量23.2465万股，换手率0.77%，振幅9.23%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.42%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Transcode Therapeutics, Inc.、Invivyd, Inc.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4655.15%、2388.12%、1767.20%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为132.24%、99.51%、75.00%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020604001196193c08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020604001196193c08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","RLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506930526","title":"Relmada Therapeutics, Inc.盘中异动 早盘股价大跌5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506930526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506930526?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:56","pubTimestamp":1737989773,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时56分，Relmada Therapeutics, Inc.股票出现波动，股价急速跳水5.94%。截至发稿，该股报0.366美元/股，成交量4.16万股，换手率0.14%，振幅2.83%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Evaxion Biotech As、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为1332.79%、160.28%、75.97%，振幅较大的相关个股有阿诺医药、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为98.54%、85.35%、65.16%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225614a231700d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225614a231700d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RLMD","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503257468","title":"Relmada Therapeutics, Inc.盘中异动 早盘股价大涨7.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503257468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503257468?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:32","pubTimestamp":1736865126,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时32分，Relmada Therapeutics, Inc.股票出现异动，股价大幅上涨7.72%。截至发稿，该股报0.435美元/股，成交量1.9783万股，换手率0.07%，振幅0.00%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Eterna Therapeutics Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Soligenix, Inc.、Phio Pharmaceuticals Corp.、Eterna Therapeutics Inc.较为活跃，换手率分别为348.45%、218.68%、112.38%，振幅较大的相关个股有Eterna Therapeutics Inc.、Fate Therapeutics, Inc.、Renovaro Inc.，振幅分别为32.98%、14.73%、13.58%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223206abaaac8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223206abaaac8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLMD","BK4007","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503588952","title":"Relmada Therapeutics, Inc.盘中异动 股价大涨7.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503588952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503588952?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:31","pubTimestamp":1736778704,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时31分，Relmada Therapeutics, Inc.股票出现波动，股价大幅上涨7.74%。截至发稿，该股报0.444美元/股，成交量1.9179万股，换手率0.06%，振幅0.00%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。其相关个股中，Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为2580.35%、1596.43%、389.66%，振幅较大的相关个股有Verrica制药、天境生物、Okyo Pharma Ltd Com Npv ，振幅分别为106.80%、106.67%、101.76%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223144aba93070&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223144aba93070&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLMD","BK4139","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495626619","title":"Relmada Therapeutics, Inc.盘中异动 股价大跌5.14%报0.435美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495626619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495626619?lang=zh_cn&edition=full","pubTime":"2024-12-31 22:40","pubTimestamp":1735656047,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日22时40分，Relmada Therapeutics, Inc.股票出现波动，股价快速下跌5.14%。截至发稿，该股报0.435美元/股，成交量30.8973万股，换手率1.02%，振幅9.83%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，知临集团、Onconetix, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃，换手率分别为1023.00%、843.14%、163.24%，振幅较大的相关个股有Onconetix, Inc.、知临集团、Eyenovia, Inc.，振幅分别为125.86%、119.56%、47.48%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231224048ab99843f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231224048ab99843f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","RLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493176545","title":"Relmada Therapeutics, Inc.盘中异动 早盘急速上涨8.57%报0.394美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493176545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493176545?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:32","pubTimestamp":1734964342,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时32分，Relmada Therapeutics, Inc.股票出现异动，股价大幅拉升8.57%。截至发稿，该股报0.394美元/股，成交量11.054万股，换手率0.37%，振幅2.76%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃，换手率分别为663.20%、440.93%、288.06%，振幅较大的相关个股有Traws Pharma, Inc.、Gt Biopharma, Inc.、Neurosense Therapeutics Ltd.，振幅分别为36.65%、33.81%、19.04%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223224a2050acc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223224a2050acc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RLMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490868978","title":"Relmada Therapeutics, Inc.盘中异动 早盘快速下挫5.87%报0.442美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490868978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490868978?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:31","pubTimestamp":1733927461,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时31分，Relmada Therapeutics, Inc.股票出现波动，股价大幅下跌5.87%。截至发稿，该股报0.442美元/股，成交量6.6861万股，换手率0.22%，振幅0.00%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Candel Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Synlogic, Inc.涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为365.60%、100.62%、97.27%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Synlogic, Inc.、Bioline Rx Ltd，振幅分别为7.69%、6.21%、5.03%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223101ab6fc977&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223101ab6fc977&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RLMD","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488197547","title":"Relmada Therapeutics, Inc.盘中异动 大幅下挫76.50%报0.651美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488197547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488197547?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:32","pubTimestamp":1733322732,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时32分，Relmada Therapeutics, Inc.股票出现波动，股价快速跳水76.50%。截至发稿，该股报0.651美元/股，成交量392.623万股，换手率13.01%，振幅2.74%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Cyclerion Therapeutics, Inc.、Heron Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为1238.61%、191.03%、111.34%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Heron Therapeutics, Inc.、Eterna Therapeutics Inc.，振幅分别为53.42%、27.97%、13.56%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223212a26c5dfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223212a26c5dfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RLMD","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488901946","title":"Relmada Therapeutics, Inc.盘中异动 早盘股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488901946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488901946?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:40","pubTimestamp":1733236803,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时40分，Relmada Therapeutics, Inc.股票出现波动，股价大幅下挫5.47%。截至发稿，该股报3.11美元/股，成交量8792股，换手率0.03%，振幅4.26%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Janux Therapeutics, Inc.、Coherus Biosciences, Inc.、Cytomx Therapeutics, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃，换手率分别为132.48%、73.75%、58.60%，振幅较大的相关个股有Coherus Biosciences, Inc.、Senti Biosciences, Inc.、Alpha Tau Medical Ltd C/Wts ，振幅分别为24.09%、23.90%、15.00%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224003abf2fcd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224003abf2fcd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","RLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2485261287","title":"Relmada Therapeutics, Inc.盘中异动 股价大涨8.00%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485261287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2485261287?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:44","pubTimestamp":1732286641,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时44分，Relmada Therapeutics, Inc.股票出现异动，股价快速上涨8.00%。截至发稿，该股报2.97美元/股，成交量2168股，换手率0.01%，振幅8.00%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Virpax Pharmaceuticals, Inc.、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为900.70%、81.41%、69.14%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为44.82%、33.24%、30.69%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224401a24e263c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224401a24e263c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLMD","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484674900","title":"Relmada Therapeutics, Inc.盘中异动 大幅拉升5.81%报3.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484674900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484674900?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:50","pubTimestamp":1731941442,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时50分，Relmada Therapeutics, Inc.股票出现波动，股价急速拉升5.81%。截至发稿，该股报3.19美元/股，成交量2.0748万股，换手率0.07%，振幅7.11%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为546.77%、384.20%、286.53%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Fate Therapeutics, Inc.，振幅分别为118.81%、71.83%、62.38%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118225043971a7302&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118225043971a7302&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","RLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484051028","title":"Relmada Therapeutics, Inc.2024财年第三财季实现净利润-21.73百万美元，同比增加1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484051028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484051028?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731773006,"startTime":"0","endTime":"0","summary":"11月17日，Relmada Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-21.73百万美元，同比增加1.23%；其中营业收入为0.00美元，每股基本收益为-0.72美元。从资产负债表来看，Relmada Therapeutics, Inc.总负债8.10百万美元，其中短期债务0.00美元，资产负债比为6.88，流动比率为6.89。机构评级：截至2024年11月17日，当前有4家机构对Relmada Therapeutics, Inc.目标价做出预测，其中目标均价为12.00美元，其中最低目标价为2.00美元，最高目标价为23.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000438a23e0727&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000438a23e0727&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2477598573","title":"Relmada Therapeutics, Inc.盘中异动 快速跳水6.47%报3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477598573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2477598573?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:45","pubTimestamp":1729608355,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时45分，Relmada Therapeutics, Inc.股票出现波动，股价急速下跌6.47%。截至发稿，该股报3.40美元/股，成交量2.7366万股，换手率0.09%，振幅2.48%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为4212.97%、3575.74%、1923.87%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Aptevo Therapeutics Inc.、Genprex, Inc.，振幅分别为165.44%、99.41%、81.46%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022224556a1e2d34a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022224556a1e2d34a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLMD","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2475685750","title":"Relmada Therapeutics, Inc.盘中异动 快速上涨5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475685750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2475685750?lang=zh_cn&edition=full","pubTime":"2024-10-15 21:36","pubTimestamp":1728999410,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日21时36分，Relmada Therapeutics, Inc.股票出现异动，股价急速上涨5.97%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Lipella Pharmaceuticals Inc.、Enveric Biosciences, Inc.、Gritstone Bio, Inc.较为活跃，换手率分别为249.50%、169.92%、144.09%，振幅较大的相关个股有Gritstone Bio, Inc.、Meiragtx Holdings Plc、Bright Minds Biosciences Inc.，振幅分别为29.63%、15.52%、14.05%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015213651971a05ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015213651971a05ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLMD","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.relmada.com","stockEarnings":[{"period":"1week","weight":0.0233},{"period":"1month","weight":-0.034},{"period":"3month","weight":-0.3301},{"period":"6month","weight":0.1695},{"period":"1year","weight":6.7765},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0044},{"period":"1month","weight":0.0363},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.1155},{"period":"1year","weight":0.202},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Relmada Therapeutics, Inc.根据内华达州法律注册成立。该公司是一家公开上市的临床阶段生物技术公司，在对其开发项目进行审查后已进行战略重心转移。它正通过许可引进和收购来推进其研发管线，其中包括一个处于2期阶段的膀胱癌候选药物和一个准备进入2b期的用于神经和代谢疾病的神经类固醇。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.038602},{"month":2,"riseRate":0.625,"avgChangeRate":0.084231},{"month":3,"riseRate":0.625,"avgChangeRate":0.044233},{"month":4,"riseRate":0.75,"avgChangeRate":0.056325},{"month":5,"riseRate":0.444444,"avgChangeRate":0.150013},{"month":6,"riseRate":0.111111,"avgChangeRate":-0.114457},{"month":7,"riseRate":0.666667,"avgChangeRate":0.048485},{"month":8,"riseRate":0.444444,"avgChangeRate":0.079273},{"month":9,"riseRate":0.875,"avgChangeRate":0.190291},{"month":10,"riseRate":0.5,"avgChangeRate":0.106137},{"month":11,"riseRate":0.375,"avgChangeRate":0.05543},{"month":12,"riseRate":0.5,"avgChangeRate":0.004602}],"exchange":"NASDAQ","name":"Relmada Therapeutics, Inc.","nameEN":"Relmada Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Relmada Therapeutics, Inc.(RLMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Relmada Therapeutics, Inc.(RLMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Relmada Therapeutics, Inc.,RLMD,Relmada Therapeutics, Inc.股票,Relmada Therapeutics, Inc.股票老虎,Relmada Therapeutics, Inc.股票老虎国际,Relmada Therapeutics, Inc.行情,Relmada Therapeutics, Inc.股票行情,Relmada Therapeutics, Inc.股价,Relmada Therapeutics, Inc.股市,Relmada Therapeutics, Inc.股票价格,Relmada Therapeutics, Inc.股票交易,Relmada Therapeutics, Inc.股票购买,Relmada Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Relmada Therapeutics, Inc.(RLMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Relmada Therapeutics, Inc.(RLMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}